Entrada Therapeutics Inc (TRDA)
18.80
+0.75
(+4.16%)
USD |
NASDAQ |
Nov 22, 16:00
18.85
+0.05
(+0.27%)
Pre-Market: 20:00
Entrada Therapeutics Price: 18.80 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 18.12 | 18.95 | 17.90 | 18.80 | 95863.00 |
| Nov 21, 2024 | 17.85 | 18.40 | 17.60 | 18.05 | 85051.00 |
| Nov 20, 2024 | 17.72 | 17.94 | 17.52 | 17.93 | 68794.00 |
| Nov 19, 2024 | 17.30 | 17.83 | 17.09 | 17.77 | 75358.00 |
| Nov 18, 2024 | 17.84 | 18.18 | 17.40 | 17.45 | 113145.0 |
| Nov 15, 2024 | 19.23 | 19.23 | 17.71 | 17.85 | 140733.0 |
| Nov 14, 2024 | 19.88 | 20.25 | 18.95 | 19.04 | 157026.0 |
| Nov 13, 2024 | 19.88 | 20.49 | 19.64 | 19.96 | 219660.0 |
| Nov 12, 2024 | 19.67 | 19.88 | 19.28 | 19.79 | 162819.0 |
| Nov 11, 2024 | 19.91 | 20.21 | 19.58 | 19.89 | 190210.0 |
| Nov 08, 2024 | 19.26 | 19.95 | 18.92 | 19.82 | 239336.0 |
| Nov 07, 2024 | 18.64 | 19.85 | 18.64 | 19.23 | 276325.0 |
| Nov 06, 2024 | 19.75 | 19.78 | 18.15 | 18.66 | 247621.0 |
| Nov 05, 2024 | 18.05 | 18.62 | 17.25 | 18.62 | 153694.0 |
| Nov 04, 2024 | 17.62 | 18.10 | 17.44 | 17.77 | 133817.0 |
| Nov 01, 2024 | 17.16 | 17.86 | 17.16 | 17.60 | 83564.00 |
| Oct 31, 2024 | 17.25 | 17.34 | 17.04 | 17.14 | 73841.00 |
| Oct 30, 2024 | 17.25 | 17.54 | 17.08 | 17.23 | 58152.00 |
| Oct 29, 2024 | 17.41 | 17.64 | 16.96 | 17.28 | 77284.00 |
| Oct 28, 2024 | 17.17 | 17.75 | 17.17 | 17.37 | 66142.00 |
| Oct 25, 2024 | 17.01 | 17.74 | 16.99 | 16.99 | 79489.00 |
| Oct 24, 2024 | 17.00 | 17.42 | 16.81 | 16.84 | 40662.00 |
| Oct 23, 2024 | 17.00 | 17.17 | 16.81 | 16.97 | 80067.00 |
| Oct 22, 2024 | 17.19 | 17.52 | 16.89 | 17.13 | 89338.00 |
| Oct 21, 2024 | 17.35 | 17.49 | 16.80 | 17.32 | 80615.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.49
Minimum
May 09 2022
35.00
Maximum
Nov 17 2021
14.48
Average
14.48
Median
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 21.48 |
| Vertex Pharmaceuticals Inc | 450.97 |
| Assembly Biosciences Inc | 15.04 |
| Sarepta Therapeutics Inc | 114.23 |
| Regenxbio Inc | 9.59 |
Price Related Metrics
| PE Ratio | 11.82 |
| PS Ratio | 3.151 |
| Price to Book Value | 1.665 |
| Earnings Yield | 8.46% |
| Market Cap | 703.50M |
| Operating PE Ratio | 11.74 |
| Normalized PE Ratio | 11.82 |